In our study we utilized a tissue micro-array with 272 fully characterized cancer cases to provide reliable data on the immunohistochemical staining pattern of both FABPs in relation to clinico-pathological parameters and on the prognostic potential of B- and L-FABP. This evidence concerns the gene FABP1 and cancer.